Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitors.

Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitors.

Oral Oncol. 2018 Mar 28;:

Authors: Sukari A, Nagasaka M, Abdallah N

Abstract
This report describes highlights the dramatic responses seen in patients who were given paclitaxel post progression on immunotherapy. There are multiple mechanisms by which synergistic effects of immunotherapy and chemotherapy occur. Further prospective studies on chemotherapy and immunotherapy are eagerly awaited.

PMID: 29605290 [PubMed - as supplied by publisher]

https://ift.tt/2Jdaubl